OpGen (OPGN)
(Delayed Data from OTC)
$2.23 USD
+0.23 (11.50%)
Updated Sep 19, 2024 10:49 AM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for OpGen, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 3 | 3 | 4 | 4 | 4 |
Cost Of Goods | 4 | 3 | 3 | 4 | 2 |
Gross Profit | 0 | -1 | 1 | 0 | 2 |
Selling & Adminstrative & Depr. & Amort Expenses | 31 | 34 | 25 | 23 | 14 |
Income After Depreciation & Amortization | -31 | -35 | -23 | -23 | -12 |
Non-Operating Income | 0 | 1 | -7 | 0 | 0 |
Interest Expense | 2 | 3 | 5 | 3 | 0 |
Pretax Income | -33 | -37 | -35 | -26 | -12 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -33 | -37 | -35 | -26 | -12 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -33 | -37 | -35 | -26 | -12 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -29 | -33 | -21 | -20 | -11 |
Depreciation & Amortization (Cash Flow) | 1 | 2 | 3 | 2 | 1 |
Income After Depreciation & Amortization | -31 | -35 | -23 | -23 | -12 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 0.79 | 0.24 | 0.18 | 0.08 | 0.01 |
Diluted EPS Before Non-Recurring Items | -38.83 | -102.10 | -186.00 | -322.00 | -1,380.00 |
Diluted Net EPS (GAAP) | -41.47 | -152.70 | -228.00 | -332.00 | -1,540.00 |
Fiscal Year end for OpGen, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.03 | 0.17 | 1.07 | 0.70 | 0.74 |
Cost Of Goods | -0.04 | 0.07 | 1.18 | 0.69 | 0.92 |
Gross Profit | 0.07 | 0.09 | -0.11 | 0.01 | -0.18 |
SG&A, R&D, and Dept/Amort Expenses | 1.61 | 1.80 | 1.79 | 3.57 | 4.98 |
Income After SG&A, R&D, and Dept/Amort Expenses | -1.54 | -1.71 | -1.90 | -3.56 | -5.16 |
Non-Operating Income | -0.03 | 2.09 | 0.06 | -0.10 | 0.01 |
Interest Expense | 0.00 | 0.00 | 0.14 | 0.40 | 0.68 |
Pretax Income | -1.58 | 0.39 | -17.04 | -4.06 | -5.83 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -1.58 | 0.39 | -17.04 | -4.06 | -5.83 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -1.58 | 0.39 | -17.04 | -4.06 | -5.83 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 1.34 | 1.33 | NA | 0.88 | 0.63 |
Diluted EPS Before Non-Recurring Items | -1.18 | 0.21 | NA | -4.60 | -9.30 |
Diluted Net EPS (GAAP) | -1.18 | 0.21 | -15.07 | -4.60 | -9.30 |